nucleus research bpc 157 BPC-157 bpc 157 at gnc BPC-157:

The potential change appears to have put doctors largely at odds with the pharmacy compounding industry: at least one poll suggests 90% of physicians are worried about patients self-directed peptide use, while compounding pharmacies argue the change would give Americans a safer supply of drugs than what they are already using

What documentation is available

For individuals managing chronic conditions, the appeal of micro-dosing lies in its sustainability

Ahead of the meeting, FDA scientists concluded that the available evidence is insufficient to support inclusion of these nominated peptides for their proposed indications